Mortality Risk After Preoperative Versus Postoperative Chemotherapy and Radiotherapy in Lymph Node–Positive Rectal Cancer

Por Seery, Tara E., Ziogas, Argyrios, Lin, Bruce S., Pan, Chuan-Ju G., Stamos, Michael J., Zell, Jason A.
Publicado em 2012

Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenib

Por Choi, Joon-Il, Imagawa, David K, Bhosale, Priya, Bhargava, Puneet, Tirkes, Temel, Seery, Tara E, Lall, Chandana
Publicado em 2014

Role of Primary Tumor Resection Among Chemotherapy-Treated Patients with Synchronous Stage IV Colorectal Cancer: A Survival Analysis

Por Tsang, Walter Y, Ziogas, Argyrios, Lin, Bruce S., Seery, Tara E., Karnes, William, Stamos, Michael J., Zell, Jason A.
Publicado em 2013

Phase 2 Study of MK-2206, an Allosteric Inhibitor of AKT, as Second-Line Therapy for Advanced Gastric and Gastroesophageal Junction Cancer: A SWOG Cooperative Group Trial (S1005)

Por Ramanathan, Ramesh K., McDonough, Shannon L., Kennecke, Hagen F., Iqbal, Syma, Baranda, Joaquina C., Seery, Tara E., Lim, Howard J., Hezel, Aram F., Vaccaro, Gina M., Blanke, Charles D.
Publicado no Cancer (2015)

Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy: SWOG S1115 Study Randomized Clinical Trial

Por Chung, Vincent, McDonough, Shannon, Philip, Philip A., Cardin, Dana, Wang-Gillam, Andrea, Hui, Laifong, Tejani, Mohamedtaki A., Seery, Tara E., Dy, Irene A., Baghdadi, Tareq Al, Hendifar, Andrew E., Doyle, L. Austin, Lowy, Andrew M., Guthrie, Katherine A., Blanke, Charles D., Hochster, Howard S.
Publicado no JAMA Oncol (2017)